Results: LPS treatment markedly increased lipid deposition, FFA contents, IL-6 and TNF-α levels, and cell apoptosis in PA treatment (NAFLD model). The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.